Steroidal nondepolarizing muscle relaxants do not simulate the effects of glucocorticoids on glucocorticoid receptor-mediated transcription in cultured skeletal muscle cells

Anesthesiology

Volumn 100, Issue 6, 2004, Pages 1615-1619

  Yasukawa, Takashi ^a   Kaneki, Masao ^a   Yasuhara, Shingo ^a   Lee, Stephanie L ^b   Martyn, J A Jeevendra ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Shriners Hospital for Children   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CHOLINERGIC RECEPTOR; DANTROLENE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LUCIFERASE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; TUBOCURARINE CHLORIDE; VECURONIUM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENERVATION; DNA RESPONSIVE ELEMENT; GENETIC TRANSFECTION; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MUSCLE ATROPHY; MUSCLE WEAKNESS; MYOBLAST; NEUROMUSCULAR BLOCKING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; MICE; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RECEPTORS, GLUCOCORTICOID; STEROIDS; TRANSCRIPTION, GENETIC;

EID: 2542472259     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200406000-00041     Document Type: Article

References (31)

1. Fletcher SN, Kennedy DD, Ghosh IR, Misra VP, Kiff K, Coakley JH, Hinds CJ: Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003; 31:1012-6
2. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS: One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348:683-93
3. De Jonghe B, Sharshar T, Lefaucheur J-P, Authier F-J, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrate F, Carlet J, Raphaël J-C, Outin H, Bastuji-Garin S: Paresis acquired in the intensive care unit: A prospective multicenter study. JAMA 2002; 288:2859-67
4. Kane SL, Dasta JF: Clinical outcomes of critical illness polyneuropathy. Pharmacotherapy 2003; 22:373-9
5. Lacomis D, Campellone JV: Critical illness neuromyopathies. Adv Neurol 2002; 88:325-35
6. Ibebunjo C, Martyn JAJ: Fiber atrophy, but not changes in acetylcholine receptor expression, contributes to the muscle dysfunction after immobilization. Crit Care Med 1999; 27:275-85
7. Hirose M, Kaneki M, Yasuhara S, Sugita H, Martyn JAJ: Immobilization depresses insulin signaling in skeletal muscle. Am J Physiol (Endo Metab) 2000; 279:E1235-41
8. Giostra E, Magistris MR, Piczolato G, Cox J, Chevrolet JC: Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Chest 1994; 106:210-20
9. de Letter MCJ, Schmitz PIM, Visser LH, Verheul FAM, Schellens RLLA, Op de Coul DAW, van der Meche FGM: Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001; 29:2281-6
10. Anesthetic and Life Support Drugs Advisory Committee Report 1992. Rockville, Maryland, United Stated Food and Drug Administration Center for Drug Evaluation and Research, November 23, 1992
11. Elliot JM, Bion JF: The use of neuromuscular blocking drugs in intensive care practice. Acta Anaesthesiol Scand Suppl 1995; 106:70-82
12. Lewis KS, Rothenburg DM: Neuromuscular blockade in the intensive care unit. Am J Health Syst Pharm 1999; 56:72-75
13. Davis NA, Rodgers JE, Gonzalez ER, Fowler AA: Prolonged weakness after cisatracurium infusion: A case report. Crit Care Med 1998; 26:1290-2
14. Meyer KC, Prielipp RC, Grossman JE, Coursin DB: Prolonged weakness after infusion of atracurium in the intensive care unit. Anesth Analg 1994; 78:772-4
15. Paradiso K, Sabey Y, Evers AS, Zorumski CF, Covey DF, Steinbach JF: Steroid inhibition of rat neuronal nicotinic alpha4 beta2 receptor expressed in HFK 293 cells. Mol Pharmacol 2000; 58:341-51
16. Kindler, Verotta D, Gray AT, Gropper MA, Yost CS: Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and neuromuscular blocking drug vecuronium. ANESTHESIOLOGY 2000; 92:821-32
17. DuBois DC, Almon RR: A possible role for glucocorticoids in denervation atrophy. Muscle Nerve 1981; 4:370-3
18. Yanez P, Martyn JAJ: Prolonged D-tubocurarine infusion and/or immobilization causes upregulation of acetylcholine receptors and hyperkalemia to succinylcholine. ANETHESIOLOGY 1996; 84:384-91
19. Hogue CW, Ward JM, Itani MS, Martyn JAJ: Tolerance and upregulation of acetylcholine receptors follows chronic infusion of d-tubocurarine. J Appl Physiol 1992; 72:1326-31
20. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM: Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1986; 318:635-41
21. Beato M, Chalepakis G, Schauer M, Slater EP: DNA regulatory elements for steroid hormones. J Steroid Biochem 1989; 32:737-47
22. Schaaf MJ, Cidlowskl JA: Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 2002; 83:37-48
23. Sanes JR, Lichtman JW: Development of the vertebrate neuromuscular junction. Annu Rev Neurosci 1999; 22:389-442
24. Matthews JC, Hori K, Cormier MJ: Substrate and substrate analogue binding properties of Renilla luciferase. Biochemistry 1977; 16:5217-20
25. de Wet JR, Wood KV, Helinski DR, DeLuca M: Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli. Proc Natl Acad Sci U S A 1985; 8223:7870-3
26. Matthews JC, Hori K, Cormier MJ: Purification and properties of Renilla reniformis luciferase. Biochemistry 1977; 16:85-91
27. Marle WV, Woods KL: Acute hydrocortisone myopathy. Br Med J 1980; 281:871-3
28. Nava S, Grayan-Ramireza, Rollier H: Effects of acute steroid administration on ventilatory and peripheral muscles in rats. Am J Respir Crit Care Med 1996; 153:1888-96
29. Shin Y-S, Fink H, Khiroya R, Ibebunjo C, Martyn JAJ Prednisolone-induced muscle dysfunction is due more to atrophy than to altered acetylcholine receptor expression. Anesth Analg 2000; 91:322-8
30. Hirose M, Kaneki M, Sugita H, Yasuhara S, Ibebunjo C, Martyn JAJ: Long-term denervation impairs insulin receptor substrate (IRS)-1-mediated insulin signaling in skeletal muscle. Metabolism 2001; 50:216-22
31. Ikezu T, Okamoto T, Yonezawa K, Tompinks RG, Martyn JAJ: Analysis of thermal injury-induced insulin resistance in rodents: Implication of post-receptor mechanism. J Biol Chem 1997; 272:25289-95